JNJ Stock Recent News

JNJ LATEST HEADLINES

JNJ Stock News Image - youtube.com

Jared Holz, Mizuho, joins 'Fast Money' to talk headwinds to the pharma sector.

youtube.com 2025 May 08
JNJ Stock News Image - businesswire.com

NEW ORLEANS--(BUSINESS WIRE)--A jury has awarded $3 million to the family of Jeanine Henderson, a 72-year-old mother from New Orleans who died from mesothelioma, a rare and incurable cancer caused by asbestos exposure, after a lifetime of using Johnson & Johnson's Baby Powder. After a two-month trial, attorneys from Dean Omar Branham Shirley successfully proved that Ms. Henderson's daily use of the talc-based powder was directly linked to her illness. The legal team also presented clear evi.

businesswire.com 2025 May 08
JNJ Stock News Image - businesswire.com

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson today announced the expansion of its efforts to champion the nursing workforce and improve access to quality care for communities around the world. These efforts are part of J&J CareCommunity, a new social impact platform that focuses the resources and expertise of J&J and J&J Foundation to support nurses at every step of their career journey and strengthen health systems worldwide. The expansion aims to help address the gl.

businesswire.com 2025 May 08
JNJ Stock News Image - seekingalpha.com

Stocks have rebounded sharply off their early-April lows, but macro risks persist. Dividend stocks have largely outperformed so far this year. We profile a pair of blue chips that recently announced dividend hikes, which has turned out to be a broader Q2 theme.

seekingalpha.com 2025 May 08
JNJ Stock News Image - youtube.com

There's no such thing as a safe stock, but these low-volatility names stand up relatively well in shaky markets.

youtube.com 2025 May 06
JNJ Stock News Image - zacks.com

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.

zacks.com 2025 May 06
JNJ Stock News Image - zacks.com

Both JNJ and ABBV expect their sales and profits to improve in 2025.

zacks.com 2025 May 06
JNJ Stock News Image - cnbc.com

President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S. The order comes ahead of Trump's planned tariffs on pharmaceuticals imported into the U.S.

cnbc.com 2025 May 05
JNJ Stock News Image - zacks.com

Most of the MedTech players have adjusted their 2025 forecasts in response to rising tariff pressure.

zacks.com 2025 May 05
JNJ Stock News Image - prnewswire.com

TREMFYA® subcutaneous induction demonstrates significant rates of clinical remission and endoscopic improvement at Week 24 in ulcerative colitis  Findings build on recent FDA-approval of both routes of administration for induction therapy with TREMFYA® in Crohn's disease   SAN DIEGO , May 5, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new data from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) subcutaneous (SC) induction therapy in adults with moderately to severely active ulcerative colitis (UC). The ASTRO Week 24 data build on the Week 12 SC induction data that showed statistically significant and clinically meaningful improvements compared to placebo across all clinical and endoscopic measures consistent with the U.S. Food and Drug Administration (FDA)-approved intravenous (IV) induction regimen evaluated in this population, in the Phase 3 QUASAR study.1,2 TREMFYA® is the first and only IL-23 inhibitor to demonstrate robust results with a full

prnewswire.com 2025 May 05
10 of 50